Cytodyn Inc (CYDY)

[ombowstring]

And if our application to uplist to NASDAQ is denied, and if the severe to critical trial isn't stopped for efficacy based on the interim look by the DSMB, and with tax loss season approaching, where might the share price be by the end of this calendar year? I'm aware of what CytoDyn potentially has going for it, but if I can re-enter the stock between $.50-$1.25, wouldn't that be the smart thing to do?

I don't know about you and the others, but I feel that we've been strung along to believe that an uplisting to NASDAQ is all but a sure thing. This is the kind of deception that fsoalex alluded to. The company can't even put out a decent pr.

I wonder how many other bills are lying around the office unpaid and collecting dust. As per Nader himself, the company has a history of being delinquent in paying its bills. Apparently, this kind of behavior continues on. How's it going to look to NASDAQ if they find out that CytoDyn is being sued for "an amount that exceeds Thirty Thousand Dollars ($30,000) exclusive of interest, costs and attorneys' fees"? They can't pay a bill for a meager $30,000+ and expect to be a NASDAQ-listed corporation?